Bosnia and Herzegovina vs Cameroon: Number of clinical trials
Bosnia and Herzegovina
7 trials
in 2024
Cameroon
7 trials
in 2024
Bosnia and Herzegovina rank
79th
Cameroon rank
79th
Number of clinical trials over time
- Bosnia and Herzegovina
- Cameroon
How they compare
Bosnia and Herzegovina currently reports 7 trials against 7 trials in Cameroon, a difference of 0 trials.
The two have swapped places 6 times across 14 shared years of data; in 2007 it was Cameroon ahead.
Bosnia and Herzegovina ranks 79th and Cameroon ranks 79th of 153 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1 trials | 3.5 trials | 2.5 trials | Cameroon |
| 2010s | 2 trials | 3.29 trials | 1.29 trials | Cameroon |
| 2020s | 5.4 trials | 5.6 trials | 0.2 trials | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Bosnia and Herzegovina or Cameroon?
- Bosnia and Herzegovina, at 7 trials against 7 trials in Cameroon as of 2024.
- What is the difference in number of clinical trials between Bosnia and Herzegovina and Cameroon?
- 0 trials, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Cameroon?
- 14 years are reported by both, from 2007 to 2024.
- How do Bosnia and Herzegovina and Cameroon rank globally for number of clinical trials?
- Bosnia and Herzegovina ranks 79th and Cameroon ranks 79th of 153 countries.
- Where does this data come from?
- ClinicalTrials.gov (2025) β with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.